Industry / Czech Republic
Healthcare Reforms Weaken Outlook For Growth
January 2011 | Industry Trend AnalysisBMI View: The Czech Republic is set to introduce major healthcare reforms in 2011 that we forecast to have damaging consequences for the country's pharmaceutical industry. The latest proposed legislation includes restricting access to expensive medicines, further reductions to drug prices and accelerated market entry for generic medicines. Health Minister Targets Expensive Medicines To Halt Exodus Of Doctors
To read the full article, please choose one of the following options:
Subcribers please log in




